Biobanking Market (By Product: Equipment, Consumables, Laboratory Information Systems; By Service: Biobanking and Repository, Validation/Qualification, Lab Processing, Cold Chain, Logistic, Others; By Biospecimen Type: Human Tissues, Stem Cells, Organs, Others; By Biobank: Physical Biobanks, Virtual Biobanks; By Application; By Ownership; By Storage Type) - Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2022 – 2030

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. Market Dynamics Analysis and Trends

5.1. Market Dynamics

5.1.1. Market Drivers

5.1.2. Market Restraints

5.1.3. Market Opportunities

5.2. Porter’s Five Forces Analysis

5.2.1. Bargaining power of suppliers

5.2.2. Bargaining power of buyers

5.2.3. Threat of substitute

5.2.4. Threat of new entrants

5.2.5. Degree of competition

Chapter 6. Competitive Landscape

6.1.1. Company Market Share/Positioning Analysis

6.1.2. Key Strategies Adopted by Players

6.1.3. Vendor Landscape

6.1.3.1. List of Suppliers

6.1.3.2. List of Buyers

Chapter 7. Global Biobanking Market, By Service

7.1. Biobanking Market, by Service, 2021-2030

7.1.1. Biobanking and Repository

7.1.1.1. Market Revenue and Forecast (2017-2030)

7.1.2. Validation/Qualification

7.1.2.1. Market Revenue and Forecast (2017-2030)

7.1.3. Lab Processing

7.1.3.1. Market Revenue and Forecast (2017-2030)

7.1.4. Cold Chain Logistic

7.1.4.1. Market Revenue and Forecast (2017-2030)

7.1.5. Other

7.1.5.1. Market Revenue and Forecast (2017-2030)

Chapter 8. Global Biobanking Market, By Product

8.1. Biobanking Market, by Product, 2021-2030

8.1.1. Equipment

8.1.1.1. Market Revenue and Forecast (2017-2030)

8.1.2. Consumables

8.1.2.1. Market Revenue and Forecast (2017-2030)

8.1.3. Laboratory Information Systems

8.1.3.1. Market Revenue and Forecast (2017-2030)

Chapter 9. Global Biobanking Market, By Biospecimen

9.1. Biobanking Market, by Biospecimen, 2021-2030

9.1.1. Human Tissues

9.1.1.1. Market Revenue and Forecast (2017-2030)

9.1.2. Stem Cells

9.1.2.1. Market Revenue and Forecast (2017-2030)

9.1.3. Organs

9.1.3.1. Market Revenue and Forecast (2017-2030)

9.1.4. Others

9.1.4.1. Market Revenue and Forecast (2017-2030)

Chapter 10. Global Biobanking Market, By Biobank

10.1. Biobanking Market, by Biobank, 2021-2030

10.1.1. Physical Biobanks

10.1.1.1. Market Revenue and Forecast (2017-2030)

10.1.2. Virtual Biobanks

10.1.2.1. Market Revenue and Forecast (2017-2030)

Chapter 11. Global Biobanking Market, By End-use

11.1. Biobanking Market, by End-use, 2021-2030

11.1.1. Drug Discovery and Clinical Research

11.1.1.1. Market Revenue and Forecast (2017-2030)

11.1.2. Therapeutics

11.1.2.1. Market Revenue and Forecast (2017-2030)

11.1.3. Clinical Diagnostics

11.1.3.1. Market Revenue and Forecast (2017-2030)

11.1.4. Others

11.1.4.1. Market Revenue and Forecast (2017-2030)

Chapter 12. Global Biobanking Market, By Type of Biobank

12.1. Biobanking Market, by Type of Biobank, 2021-2030

12.1.1. Population-based Biobanks

12.1.1.1. Market Revenue and Forecast (2017-2030)

12.1.2. Disease-oriented Biobanks

12.1.2.1. Market Revenue and Forecast (2017-2030)

Chapter 13. Global Biobanking Market, By Ownership

13.1. Biobanking Market, by Ownership, 2021-2030

13.1.1. National/regional agency

13.1.1.1. Market Revenue and Forecast (2017-2030)

13.1.2. Non-Profit Organization

13.1.2.1. Market Revenue and Forecast (2017-2030)

13.1.3. Universities

13.1.3.1. Market Revenue and Forecast (2017-2030)

13.1.4. Private Organization

13.1.4.1. Market Revenue and Forecast (2017-2030)

Chapter 14. Global Biobanking Market, Regional Estimates and Trend Forecast

14.1. North America

14.1.1. Market Revenue and Forecast, by Service (2017-2030)

14.1.2. Market Revenue and Forecast, by Product (2017-2030)

14.1.3. Market Revenue and Forecast, by Biospecimen (2017-2030)

14.1.4. Market Revenue and Forecast, by Biobank (2017-2030)

14.1.5. Market Revenue and Forecast, by End-use (2017-2030)

14.1.6. Market Revenue and Forecast, by Ownership (2017-2030)

14.1.7. Market Revenue and Forecast, by Type of Biobank (2017-2030)

14.1.8. U.S.

14.1.8.1. Market Revenue and Forecast, by Service (2017-2030)

14.1.8.2. Market Revenue and Forecast, by Product (2017-2030)

14.1.8.3. Market Revenue and Forecast, by Biospecimen (2017-2030)

14.1.8.4. Market Revenue and Forecast, by Biobank (2017-2030)

14.1.8.5. Market Revenue and Forecast, by End-use (2017-2030)

14.1.8.6. Market Revenue and Forecast, by Ownership (2017-2030)

14.1.8.7. Market Revenue and Forecast, by Type of Biobank (2017-2030)

14.1.9. Rest of North America

14.1.9.1. Market Revenue and Forecast, by Service (2017-2030)

14.1.9.2. Market Revenue and Forecast, by Product (2017-2030)

14.1.9.3. Market Revenue and Forecast, by Biospecimen (2017-2030)

14.1.9.4. Market Revenue and Forecast, by Biobank (2017-2030)

14.1.9.5. Market Revenue and Forecast, by End-use (2017-2030)

14.1.9.6. Market Revenue and Forecast, by Ownership (2017-2030)

14.1.9.7. Market Revenue and Forecast, by Type of Biobank (2017-2030)

14.2. Europe

14.2.1. Market Revenue and Forecast, by Service (2017-2030)

14.2.2. Market Revenue and Forecast, by Product (2017-2030)

14.2.3. Market Revenue and Forecast, by Biospecimen (2017-2030)

14.2.4. Market Revenue and Forecast, by Biobank (2017-2030)

14.2.5. Market Revenue and Forecast, by End-use (2017-2030)

14.2.6. Market Revenue and Forecast, by Ownership (2017-2030)

14.2.7. Market Revenue and Forecast, by Type of Biobank (2017-2030)

14.2.8. UK

14.2.8.1. Market Revenue and Forecast, by Service (2017-2030)

14.2.8.2. Market Revenue and Forecast, by Product (2017-2030)

14.2.8.3. Market Revenue and Forecast, by Biospecimen (2017-2030)

14.2.8.4. Market Revenue and Forecast, by Biobank (2017-2030)

14.2.8.5. Market Revenue and Forecast, by End-use (2017-2030)

14.2.8.6. Market Revenue and Forecast, by Ownership (2017-2030)

14.2.8.7. Market Revenue and Forecast, by Type of Biobank (2017-2030)

14.2.9. Germany

14.2.9.1. Market Revenue and Forecast, by Service (2017-2030)

14.2.9.2. Market Revenue and Forecast, by Product (2017-2030)

14.2.9.3. Market Revenue and Forecast, by Biospecimen (2017-2030)

14.2.9.4. Market Revenue and Forecast, by Biobank (2017-2030)

14.2.9.5. Market Revenue and Forecast, by End-use (2017-2030)

14.2.9.6. Market Revenue and Forecast, by Ownership (2017-2030)

14.2.9.7. Market Revenue and Forecast, by Type of Biobank (2017-2030)

14.2.10. France

14.2.10.1. Market Revenue and Forecast, by Service (2017-2030)

14.2.10.2. Market Revenue and Forecast, by Product (2017-2030)

14.2.10.3. Market Revenue and Forecast, by Biospecimen (2017-2030)

14.2.10.4. Market Revenue and Forecast, by Biobank (2017-2030)

14.2.10.5. Market Revenue and Forecast, by End-use (2017-2030)

14.2.10.6. Market Revenue and Forecast, by Ownership (2017-2030)

14.2.10.7. Market Revenue and Forecast, by Type of Biobank (2017-2030)

14.2.11. Rest of Europe

14.2.11.1. Market Revenue and Forecast, by Service (2017-2030)

14.2.11.2. Market Revenue and Forecast, by Product (2017-2030)

14.2.11.3. Market Revenue and Forecast, by Biospecimen (2017-2030)

14.2.11.4. Market Revenue and Forecast, by Biobank (2017-2030)

14.2.11.5. Market Revenue and Forecast, by End-use (2017-2030)

14.2.11.6. Market Revenue and Forecast, by Ownership (2017-2030)

14.2.11.7. Market Revenue and Forecast, by Type of Biobank (2017-2030)

14.3. APAC

14.3.1. Market Revenue and Forecast, by Service (2017-2030)

14.3.2. Market Revenue and Forecast, by Product (2017-2030)

14.3.3. Market Revenue and Forecast, by Biospecimen (2017-2030)

14.3.4. Market Revenue and Forecast, by Biobank (2017-2030)

14.3.5. Market Revenue and Forecast, by End-use (2017-2030)

14.3.6. Market Revenue and Forecast, by Ownership (2017-2030)

14.3.7. Market Revenue and Forecast, by Type of Biobank (2017-2030)

14.3.8. India

14.3.8.1. Market Revenue and Forecast, by Service (2017-2030)

14.3.8.2. Market Revenue and Forecast, by Product (2017-2030)

14.3.8.3. Market Revenue and Forecast, by Biospecimen (2017-2030)

14.3.8.4. Market Revenue and Forecast, by Biobank (2017-2030)

14.3.8.5. Market Revenue and Forecast, by End-use (2017-2030)

14.3.8.6. Market Revenue and Forecast, by Ownership (2017-2030)

14.3.8.7. Market Revenue and Forecast, by Type of Biobank (2017-2030)

14.3.9. China

14.3.9.1. Market Revenue and Forecast, by Service (2017-2030)

14.3.9.2. Market Revenue and Forecast, by Product (2017-2030)

14.3.9.3. Market Revenue and Forecast, by Biospecimen (2017-2030)

14.3.9.4. Market Revenue and Forecast, by Biobank (2017-2030)

14.3.9.5. Market Revenue and Forecast, by End-use (2017-2030)

14.3.9.6. Market Revenue and Forecast, by Ownership (2017-2030)

14.3.9.7. Market Revenue and Forecast, by Type of Biobank (2017-2030)

14.3.10. Japan

14.3.10.1. Market Revenue and Forecast, by Service (2017-2030)

14.3.10.2. Market Revenue and Forecast, by Product (2017-2030)

14.3.10.3. Market Revenue and Forecast, by Biospecimen (2017-2030)

14.3.10.4. Market Revenue and Forecast, by Biobank (2017-2030)

14.3.10.5. Market Revenue and Forecast, by End-use (2017-2030)

14.3.10.6. Market Revenue and Forecast, by Ownership (2017-2030)

14.3.10.7. Market Revenue and Forecast, by Type of Biobank (2017-2030)

14.3.11. Rest of APAC

14.3.11.1. Market Revenue and Forecast, by Service (2017-2030)

14.3.11.2. Market Revenue and Forecast, by Product (2017-2030)

14.3.11.3. Market Revenue and Forecast, by Biospecimen (2017-2030)

14.3.11.4. Market Revenue and Forecast, by Biobank (2017-2030)

14.3.11.5. Market Revenue and Forecast, by End-use (2017-2030)

14.3.11.6. Market Revenue and Forecast, by Ownership (2017-2030)

14.3.11.7. Market Revenue and Forecast, by Type of Biobank (2017-2030)

14.4. MEA

14.4.1. Market Revenue and Forecast, by Service (2017-2030)

14.4.2. Market Revenue and Forecast, by Product (2017-2030)

14.4.3. Market Revenue and Forecast, by Biospecimen (2017-2030)

14.4.4. Market Revenue and Forecast, by Biobank (2017-2030)

14.4.5. Market Revenue and Forecast, by End-use (2017-2030)

14.4.6. Market Revenue and Forecast, by Ownership (2017-2030)

14.4.7. Market Revenue and Forecast, by Type of Biobank (2017-2030)

14.4.8. GCC

14.4.8.1. Market Revenue and Forecast, by Service (2017-2030)

14.4.8.2. Market Revenue and Forecast, by Product (2017-2030)

14.4.8.3. Market Revenue and Forecast, by Biospecimen (2017-2030)

14.4.8.4. Market Revenue and Forecast, by Biobank (2017-2030)

14.4.8.5. Market Revenue and Forecast, by End-use (2017-2030)

14.4.8.6. Market Revenue and Forecast, by Ownership (2017-2030)

14.4.8.7. Market Revenue and Forecast, by Type of Biobank (2017-2030)

14.4.9. North Africa

14.4.9.1. Market Revenue and Forecast, by Service (2017-2030)

14.4.9.2. Market Revenue and Forecast, by Product (2017-2030)

14.4.9.3. Market Revenue and Forecast, by Biospecimen (2017-2030)

14.4.9.4. Market Revenue and Forecast, by Biobank (2017-2030)

14.4.9.5. Market Revenue and Forecast, by End-use (2017-2030)

14.4.9.6. Market Revenue and Forecast, by Ownership (2017-2030)

14.4.9.7. Market Revenue and Forecast, by Type of Biobank (2017-2030)

14.4.10. South Africa

14.4.10.1. Market Revenue and Forecast, by Service (2017-2030)

14.4.10.2. Market Revenue and Forecast, by Product (2017-2030)

14.4.10.3. Market Revenue and Forecast, by Biospecimen (2017-2030)

14.4.10.4. Market Revenue and Forecast, by Biobank (2017-2030)

14.4.10.5. Market Revenue and Forecast, by End-use (2017-2030)

14.4.10.6. Market Revenue and Forecast, by Ownership (2017-2030)

14.4.10.7. Market Revenue and Forecast, by Type of Biobank (2017-2030)

14.4.11. Rest of MEA

14.4.11.1. Market Revenue and Forecast, by Service (2017-2030)

14.4.11.2. Market Revenue and Forecast, by Product (2017-2030)

14.4.11.3. Market Revenue and Forecast, by Biospecimen (2017-2030)

14.4.11.4. Market Revenue and Forecast, by Biobank (2017-2030)

14.4.11.5. Market Revenue and Forecast, by End-use (2017-2030)

14.4.11.6. Market Revenue and Forecast, by Ownership (2017-2030)

14.4.11.7. Market Revenue and Forecast, by Type of Biobank (2017-2030)

14.5. Latin America

14.5.1. Market Revenue and Forecast, by Service (2017-2030)

14.5.2. Market Revenue and Forecast, by Product (2017-2030)

14.5.3. Market Revenue and Forecast, by Biospecimen (2017-2030)

14.5.4. Market Revenue and Forecast, by Biobank (2017-2030)

14.5.5. Market Revenue and Forecast, by End-use (2017-2030)

14.5.6. Market Revenue and Forecast, by Ownership (2017-2030)

14.5.7. Market Revenue and Forecast, by Type of Biobank (2017-2030)

14.5.8. Brazil

14.5.8.1. Market Revenue and Forecast, by Service (2017-2030)

14.5.8.2. Market Revenue and Forecast, by Product (2017-2030)

14.5.8.3. Market Revenue and Forecast, by Biospecimen (2017-2030)

14.5.8.4. Market Revenue and Forecast, by Biobank (2017-2030)

14.5.8.5. Market Revenue and Forecast, by End-use (2017-2030)

14.5.8.6. Market Revenue and Forecast, by Ownership (2017-2030)

14.5.8.7. Market Revenue and Forecast, by Type of Biobank (2017-2030)

14.5.9. Rest of LATAM

14.5.9.1. Market Revenue and Forecast, by Service (2017-2030)

14.5.9.2. Market Revenue and Forecast, by Product (2017-2030)

14.5.9.3. Market Revenue and Forecast, by Biospecimen (2017-2030)

14.5.9.4. Market Revenue and Forecast, by Biobank (2017-2030)

14.5.9.5. Market Revenue and Forecast, by End-use (2017-2030)

14.5.9.6. Market Revenue and Forecast, by Ownership (2017-2030)

14.5.9.7. Market Revenue and Forecast, by Type of Biobank (2017-2030)

Chapter 15. Company Profiles

15.1. Thermo Fisher Scientific Inc.

15.1.1. Company Overview

15.1.2. Product Offerings

15.1.3. Financial Performance

15.1.4. Recent Initiatives

15.2. Tecan Trading AG

15.2.1. Company Overview

15.2.2. Product Offerings

15.2.3. Financial Performance

15.2.4. Recent Initiatives

15.3. QIAGEN

15.3.1. Company Overview

15.3.2. Product Offerings

15.3.3. Financial Performance

15.3.4. Recent Initiatives

15.4. Hamilton Company

15.4.1. Company Overview

15.4.2. Product Offerings

15.4.3. Financial Performance

15.4.4. Recent Initiatives

15.5. Brooks Life Sciences

15.5.1. Company Overview

15.5.2. Product Offerings

15.5.3. Financial Performance

15.5.4. Recent Initiatives

15.6. TTP Labtech

15.6.1. Company Overview

15.6.2. Product Offerings

15.6.3. Financial Performance

15.6.4. Recent Initiatives

15.7. VWR International, LLC.

15.7.1. Company Overview

15.7.2. Product Offerings

15.7.3. Financial Performance

15.7.4. Recent Initiatives

15.8. Promega Corporation

15.8.1. Company Overview

15.8.2. Product Offerings

15.8.3. Financial Performance

15.8.4. Recent Initiatives

15.9. Worthington Industries

15.9.1. Company Overview

15.9.2. Product Offerings

15.9.3. Financial Performance

15.9.4. Recent Initiatives

15.10. BD

15.10.1. Company Overview

15.10.2. Product Offerings

15.10.3. Financial Performance

15.10.4. Recent Initiatives

15.11. Merck KGaA

15.11.1. Company Overview

15.11.2. Product Offerings

15.11.3. Financial Performance

15.11.4. Recent Initiatives

15.12. Biokryo GmbH

15.12.1. Company Overview

15.12.2. Product Offerings

15.12.3. Financial Performance

15.12.4. Recent Initiatives

15.13. Cell&Co BioServices

15.13.1. Company Overview

15.13.2. Product Offerings

15.13.3. Financial Performance

15.13.4. Recent Initiatives

Chapter 16. Research Methodology

16.1. Primary Research

16.2. Secondary Research

16.3. Assumptions

Chapter 17. Appendix

17.1. About Us

17.2. Glossary of Terms

PROCEED TO BUY

   USD 4900.00
   USD 7000
   USD 9000

ASK FOR SAMPLE

No cookie-cutter, only authentic analysis – take the 1st step to become an Precedence Research client

Get a Sample